### ü§ñ AI for Good - Insights on AI, Human Performance, and Longevity

This article summarizes a presentation by Alex Zhavoronkov at the AI for Good Global Summit 2025, focusing on the intersection of AI, human performance, and longevity.  The presentation offers insights into leveraging AI to improve human health and lifespan.


Key Points:

‚Ä¢  Insights into AI's role in enhancing human performance.

‚Ä¢  Exploration of AI's potential to extend human longevity.

‚Ä¢  Discussion of the ethical considerations surrounding AI in healthcare.


üîó Resources:

‚Ä¢ [InSilicoMeds](https://x.com/InSilicoMeds) -  AI for drug discovery and longevity research

‚Ä¢ [AI for Good Global Summit 2025](https://x.com/AIforGood) -  Global summit focused on AI for positive change

![Image](https://pbs.twimg.com/media/Gp75D4sWAAA0YOk?format=jpg&name=small)


---
### ü§ñ AACR 2025 - Conference Summary

This article summarizes InSilicoMeds' experience at the AACR 2025 conference in Chicago, highlighting the event's scale and the company's engagement with researchers and clinicians.


Key Points:

‚Ä¢  Over 22,000 attendees at the AACR 2025 conference.

‚Ä¢  InSilicoMeds' participation and networking opportunities.

‚Ä¢  Positive experience and gratitude towards organizers and the city of Chicago.


üîó Resources:

‚Ä¢ [InSilicoMeds](https://x.com/InSilicoMeds) -  AI-driven drug discovery company

![Image](https://pbs.twimg.com/media/Gp8u9nSXoAA5Dgj?format=jpg&name=small)
![Image](https://pbs.twimg.com/media/Gp8u-IOW8AEQiNm?format=jpg&name=360x360)
![Image](https://pbs.twimg.com/media/Gp8u-n8WUAAdvFh?format=jpg&name=360x360)


---
### üöÄ Business - Butterfly Network's 2025 Growth

This article reports on Butterfly Network's positive 2025 first-quarter performance, exceeding growth guidance and showcasing progress on key initiatives.


Key Points:

‚Ä¢  Exceeded growth guidance for the first quarter of 2025.

‚Ä¢  Steady momentum across the business.

‚Ä¢  Progress on key initiatives within the 5-year plan.


üîó Resources:

‚Ä¢ [Butterfly Network](https://x.com/ButterflyNetInc) -  Medical imaging technology company

‚Ä¢ [Earnings Release](http://bwnews.pr/4lYjuTU) -  Financial report for Q1 2025

![Image](https://pbs.twimg.com/media/Gp8EBuSX0AEoZam?format=jpg&name=small)


---
### ü§ñ AI in Healthcare - Owkin's RlapsRisk¬Æ BC AI Diagnostic

This article describes Owkin's RlapsRisk¬Æ BC AI diagnostic tool for early breast cancer, showcasing its application in assisting pathologists and oncologists in determining appropriate treatment pathways.


Key Points:

‚Ä¢  AI diagnostic tool for early breast cancer.

‚Ä¢  Assists pathologists and oncologists in treatment decisions.

‚Ä¢  Developed through a collaborative project.


üîó Resources:

‚Ä¢ [Owkin](https://x.com/OwkinScience) -  AI-driven healthcare company

![Image](https://pbs.twimg.com/amplify_video_thumb/1918235993481625600/img/Oj1KXgNvI8v0QPg5.jpg)


---
### ü§ñ Health Tech - Rejuve AI App and Melatonin Production

This article discusses a user's experience with the Rejuve AI app, highlighting its ability to track sleep patterns, provide personalized wind-down routines, and reward users with tokens for data syncing.


Key Points:

‚Ä¢  Tracks sleep patterns and melatonin production.

‚Ä¢  Provides personalized wind-down routines.

‚Ä¢  Rewards users with tokens for data synchronization.


üîó Resources:

‚Ä¢ [Rejuve AI](https://x.com/Rejuve_AI) -  AI-powered health and wellness app

![Image](https://pbs.twimg.com/media/Gp2BdckWMAIXwHN?format=jpg&name=small)


---
### ü§ñ AI in Drug Development - Owkin's Agentic AI Co-pilot for ADCs

This article highlights Owkin's agentic AI co-pilot, designed to address the complexities in antibody-drug conjugate (ADC) development, as discussed at the AACR conference.


Key Points:

‚Ä¢  Addresses challenges in antibody-drug conjugate (ADC) development.

‚Ä¢  Agentic AI co-pilot assists in streamlining the development process.

‚Ä¢  Presented at the AACR conference.


üîó Resources:

‚Ä¢ [Owkin](https://x.com/OwkinScience) - AI-driven healthcare company

‚Ä¢ [AACR](https://x.com/AACR) - American Association for Cancer Research

![Image](https://pbs.twimg.com/amplify_video_thumb/1917847641641160704/img/yqdyVHQV4Wi3Mfjl.jpg)


---
### üí° Social Media - Experiment in Social Media Posting

This article briefly describes a social media experiment focusing on liking posts instead of retweeting, and its impact on engagement. The author plans to discuss the results on a social media show.


Key Points:

‚Ä¢  Experiment in social media posting strategy.

‚Ä¢  Focus on liking instead of retweeting.

‚Ä¢  Results to be discussed on a later social media show.


---
### ü§ñ AI in Healthcare - AI-Powered Chest X-rays for Lung Cancer Detection

This article discusses the use of AI-powered chest X-rays in improving lung cancer detection, particularly in nonsmokers.  It highlights a partnership between qure.ai and AstraZeneca to improve access to this technology.


Key Points:

‚Ä¢  Up to 20% of lung cancer cases occur in nonsmokers.

‚Ä¢  AI-powered chest X-rays improve early detection.

‚Ä¢  Partnership between qure.ai and AstraZeneca to enhance access.


üîó Resources:

‚Ä¢ [qure.ai](https://x.com/qure_ai) -  AI-driven medical imaging company

‚Ä¢ [AstraZeneca](https://x.com/AstraZeneca) -  Pharmaceutical company

![Image](https://pbs.twimg.com/amplify_video_thumb/1917648342970163204/img/oezC3xeIkAggD39m.jpg)


---
### ü§ñ AI and Robotics - Physical AI at SXSW 2025

This article summarizes a discussion at SXSW 2025 on the "dawn of physical AI," featuring industry leaders from Cadence, Amazon Robotics, and other organizations.


Key Points:

‚Ä¢  Discussion on the emerging field of physical AI.

‚Ä¢  Contributions from industry leaders across various sectors.

‚Ä¢  Presentation at SXSW 2025.


üîó Resources:

‚Ä¢ [Diligent Robots](https://x.com/DiligentRobots) -  Robotics company

‚Ä¢ [Cadence](https://x.com/Cadence) -  Electronic design automation company

‚Ä¢ [Amazon Robotics](https://x.com/amazon) -  Robotics division of Amazon

![Image](https://pbs.twimg.com/media/GoBh0uyWEAAFPBA?format=jpg&name=small)


---
### ü§ñ Cancer Diagnostics - Tempus' Pan-Cancer Laboratory Developed Test

This article announces the launch of a pan-cancer laboratory developed test using RNA-seq data and algorithms to predict IHC results for key biomarkers.


Key Points:

‚Ä¢  Pan-cancer laboratory developed test launched.

‚Ä¢  Uses RNA-seq data and algorithms for prediction.

‚Ä¢  Predicts IHC results for biomarkers like HER2 and TROP2.


üîó Resources:

‚Ä¢ [Tempus](https://x.com/TempusAI) -  AI-driven healthcare company

![Image](https://pbs.twimg.com/media/GpuIF-oXsAAImcZ?format=jpg&name=small)


---

### ‚≠êÔ∏è Support

If you liked reading this report, please star ‚≠êÔ∏è this repository and follow me on [Github](https://github.com/Drix10), [ùïè (previously known as Twitter)](https://x.com/DRIX_10_) to help others discover these resources and regular updates.

---